6.
Hatano S
. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976; 54(5):541-53.
PMC: 2366492.
View
7.
Jaberinezhad M, Farhoudi M, Nejadghaderi S, Alizadeh M, Sullman M, Carson-Chahhoud K
. The burden of stroke and its attributable risk factors in the Middle East and North Africa region, 1990-2019. Sci Rep. 2022; 12(1):2700.
PMC: 8854638.
DOI: 10.1038/s41598-022-06418-x.
View
8.
Wei W, Li S, San F, Zhang S, Shen Q, Guo J
. Retrospective analysis of prognosis and risk factors of patients with stroke by TOAST. Medicine (Baltimore). 2018; 97(15):e0412.
PMC: 5908632.
DOI: 10.1097/MD.0000000000010412.
View
9.
Horvath E, Vadasdi K, Vastagh I, Folyovich A
. Role of diagnosis of dyslipidemia in primary and secondary vascular prevention in a neurology department. Ideggyogy Sz. 2010; 63(3-4):121-4.
View
10.
Akhtar N, Salam A, Kamran S, Bourke P, Joseph S, Santos M
. Ethnic variation in acute cerebrovascular disease: Analysis from the Qatar stroke registry. Eur Stroke J. 2019; 1(3):231-241.
PMC: 6301242.
DOI: 10.1177/2396987316663776.
View
11.
Giralt-Steinhauer E, Cuadrado-Godia E, Soriano-Tarraga C, Ois A, Jimenez-Conde J, Rodriguez-Campello A
. New-Onset Paroxysmal Atrial Fibrillation Diagnosis in Ischemic Stroke Patients. Eur Neurol. 2015; 74(3-4):211-7.
DOI: 10.1159/000441187.
View
12.
Mima Y, Kuwashiro T, Yasaka M, Tsurusaki Y, Nakamura A, Wakugawa Y
. Impact of Metformin on the Severity and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus. J Stroke Cerebrovasc Dis. 2016; 25(2):436-46.
DOI: 10.1016/j.jstrokecerebrovasdis.2015.10.016.
View
13.
Wannamethee S, Shaper A, Ebrahim S
. HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke. 2000; 31(8):1882-8.
DOI: 10.1161/01.str.31.8.1882.
View
14.
Amarenco P, Goldstein L, Callahan 3rd A, Sillesen H, Hennerici M, ONeill B
. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2008; 204(2):515-20.
DOI: 10.1016/j.atherosclerosis.2008.09.008.
View
15.
Al Rukn S, Mazya M, Hentati F, Ben Sassi S, Nabli F, Said Z
. Stroke in the Middle-East and North Africa: A 2-year prospective observational study of stroke characteristics in the region-Results from the Safe Implementation of Treatments in Stroke (SITS)-Middle-East and North African (MENA). Int J Stroke. 2019; 14(7):715-722.
DOI: 10.1177/1747493019830331.
View
16.
Ospel J, Goyal M
. A review of endovascular treatment for medium vessel occlusion stroke. J Neurointerv Surg. 2021; 13(7):623-630.
DOI: 10.1136/neurintsurg-2021-017321.
View
17.
Lei C, Wu B, Liu M, Chen Y
. Association between hemoglobin A₁C levels and clinical outcome in ischemic stroke patients with or without diabetes. J Clin Neurosci. 2015; 22(3):498-503.
DOI: 10.1016/j.jocn.2014.08.030.
View
18.
Carlberg B, Asplund K, Hagg E
. The prognostic value of admission blood pressure in patients with acute stroke. Stroke. 1993; 24(9):1372-5.
DOI: 10.1161/01.str.24.9.1372.
View
19.
Touma L, Filion K, Sterling L, Atallah R, Windle S, Eisenberg M
. Stent Retrievers for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Neurol. 2016; 73(3):275-81.
DOI: 10.1001/jamaneurol.2015.4441.
View
20.
Lattanzi S, Silvestrini M
. Blood pressure in acute intra-cerebral hemorrhage. Ann Transl Med. 2016; 4(16):320.
PMC: 5009017.
DOI: 10.21037/atm.2016.08.04.
View